Association between the dynamics of the COVID-19 epidemic and ABO blood type distribution. (7th January 2021)

• Record Type: Journal Article
• Authors: Liu, Yuefei; Häussinger, Lisa; Steinacker, Jürgen M.; Dinse-Lambracht, Alexander
• Is Part Of: Epidemiology and infection. Volume 149(2021)
• Publication Date: 2021-01-07
• Subjects: ABO blood types, -- COVID-19, -- epidemic, -- infectious disease, -- pandemic, -- SARS-CoV-2; Communicable diseases -- Periodicals; Epidemiology -- Periodicals; 614.4
• DOI: 10.1017/S0950268821000030
• Languages: English
• ISSNs: 0950-2688

Abstract

Abstract: The coronavirus disease 2019 (COVID-19) pandemic is currently the most critical challenge in public health. An understanding of the factors that affect severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection will help fight the COVID-19 pandemic. This study sought to investigate the association between SARS-CoV-2 infection and blood type distribution. The big data provided by the World Health Organization (WHO) and Johns Hopkins University were used to assess the dynamics of the COVID-19 epidemic. The infection data in the early phase of the pandemic from six countries in each of six geographic zones divided according to the WHO were used, representing approximately 5.4 billion people around the globe. We calculated the infection growth factor, doubling times of infection and death cases, reproductive number and infection and death cases in relation to the blood type distribution. The growth factor of infection and death cases significantly and positively correlated with the proportion of the population with blood type A and negatively correlated with the proportion of the population with blood type B. Compared with the lower blood type A population (<30%), the higher blood type A population (⩾30%) showed more infection and death cases, higher growth factors and shorter case doubling times for infections and deaths and thus higher epidemic dynamics. Thus, an association exists between SARS-CoV-2 and the ABO blood group distribution, which might be useful for fighting the COVID-19 pandemic.